George Poulogiannis

George Poulogiannis

Company: Institute of Cancer Research

Job title: Team Leader, Signalling & Cancer Metabolism Group


Harnessing Metabolism to Optimize Kinase Therapeutic Responses & Overcome Resistance 4:00 pm

Deconstructing the metabolic signatures associated with the response of kinase inhibitors to inform target selection Targeting metabolism through a drug and diet combination to enhance the response to targeted therapies and overcome resistance Leveraging pre-clinical data to assess the potential to advance to clinical trials and treat cancer cases, patient by patientRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.